Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Pimozide MeSH Descriptor Data 2026


MeSH Heading
Pimozide
Tree Number(s)
D03.633.100.103.732
Unique ID
D010868
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D010868
Scope Note
A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403)
Entry Term(s)
Antalon
Orap
Orap forte
R-6238
Pharm Action
Antipsychotic Agents
Dopamine Antagonists
Anti-Dyskinesia Agents
Registry Numbers
1HIZ4DL86F
0
Related Numbers
2062-78-4
CAS Type 1 Name
2H-Benzimidazol-2-one, 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-
Previous Indexing
Benzimidazoles (1966-1972)
Tranquilizing Agents (1966-1972)
Public MeSH Note
73
History Note
73
Date Introduced
1973/01/01
Last Updated
2017/05/24
Pimozide Preferred
R-6238 Narrower
Antalon Narrower
Orap Narrower
page delivered in 0.139s